Life Scientist > Biotechnology

Clinuvel granted orphan designation

29 July, 2008 by Dylan Bushell-Embling

Clinuvel's CUV1647 granted orphan drug designation by US FDA


Tutti frutti for Kiwis

29 July, 2008 by Dylan Bushell-Embling

Large EST library for kiwifruit published, fleshing out apples and pears


Life to appeal Federal Court decision

29 July, 2008 by Dylan Bushell-Embling

Life Therapeutics to appeal federal court decision preventing its planned share sale


LCT is US-bound

29 July, 2008 by Dylan Bushell-Embling

Living Cell Technologies appoints new US-based CEO


CogState releases details of UBC agreement

29 July, 2008 by Dylan Bushell-Embling

Parties will combine to launch a new product but will remain separate entities


Biotech: worst year on record

29 July, 2008 by Kate McDonald

Final quarter of FY08 down again, year the worst on record: PwC


Bacteria eaters win out

29 July, 2008 by Kate McDonald

Special Phage Holdings wins NSW commercialisation award


Arana expands clinical research

28 July, 2008 by Kate McDonald

Arana Therapeutics adds new face to clinical research team


IP Australia sits US exams

25 July, 2008 by Staff Writers

IP Australia named as search and examination authority for US patent office


Flu's up for Rockeby

24 July, 2008 by Dylan Bushell-Embling

Rockeby receives $252,000 worth of orders for bird flu test


Eye and ear on bionics

24 July, 2008 by Kate McDonald

Centre for bionics for NSW, international conference for Victoria


More for AtCor

24 July, 2008 by Dylan Bushell-Embling

AtCor wins two more supply contracts for SphygmoCor, worth $1.66M


GTG responds to BRCA row

24 July, 2008 by Dylan Bushell-Embling

Genetic Technologies responds to criticism over patent enforcement decision


Freeze my puppies

23 July, 2008 by Dylan Bushell-Embling

Genetic Technologies acquires Frozen Puppies Dot Com


Anadis begins trials for IBD

23 July, 2008 by Dylan Bushell-Embling and Kate McDonald

Israeli trial due for completion in 2009, commercialisation as nutritional to follow


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd